Science. Quality. Responsibility.

Since 1971, SPMD-RfB have been committed to the highest quality in laboratory medicine. Our work combines independent quality assurance with scientific promotion – nationally and internationally.

ISO 17043 accredited

Employees

Scientific Advisors

EQA Schemes

Participations/year

Countries are supplied worldwide

Who we are

RfB, part of the Foundation for Pathobiochemistry and Molecular Diagnostics (SPMD), is Germany’s official non-profit provider of External Quality Assurance (EQA) in laboratory medicine.
Founded in 1971, RfB operates from sites in Bonn, Cologne, and Hanover. The organization is accredited in accordance with ISO/IEC 17043 and is listed by the German Medical Association (BÄK). All procedures comply with the Association’s strict guidelines. In addition, RfB operates two calibration laboratories accredited to ISO/IEC 17025 and ISO 15195, ensuring accuracy, reliability, and full metrological traceability. These laboratories are listed in the international JCTLM database.

Evolution of SPMD-RfB

1971

Foundation of RfB (Reference Institute for Bioanalytics), starting with EQA schemes for 13 measurands

1981

Use of traceable RMV (reference measurement values) as target values for selected metabolites and hormones

1994

20 different EQA schemes with more than 100 analytes

2000

EQA schemes for Moleculare Genetics established

2007

Starting with EQA schemes in the section microbiology

2010

First EQA schemes for immunology and serology established

2011

RfB is managed under the umbrella of SPMD (Foundation for Pathobiochemistry and Molecular Diagnostics)

2016

Continuous expansion of the portfolio to 110 + EQA schemes with 820 + analytes

2023

Expansion of international activities and development of education programs

2025

New EQA concepts for NGS analysis and digitalisation of process

Mission & Values

Our mission is to strengthen patient safety and continuously advance laboratory medicine through external quality control and scientific promotion. In doing so, we follow clear principles that shape our daily actions:

Patient safety first

Quality assurance as the basis for accurate diagnoses and safe therapies.

Transparency & Trust

Open evaluations, individual reports, neutral procedures.

Education & Innovation

Promotion of knowledge transfer, training, and further development.

Our Team

More than 50 employees at our locations in Bonn, Cologne, and Hanover are committed to ensuring the quality of laboratory diagnostics on a daily basis. We are supported by over 40 scientific advisors from universities and clinics who contribute their expertise to our programs. Together, we are working to make laboratory results comparable and reliable worldwide.

Gunther Schabio 

Dr. Anja Kessler

Dr. Stefanie Gemein

Committees we sit on

Scientific governance

Scientific Coordinator & Reviewer of the SPMD

Scientific Secretary
Prof. Dr. med. Andreas Fischer

Position: Director of the Institute of Clinical Chemistry and Laboratory Medicine, Universitätsklinikum Mannheim

Main research areas:

  • Clinical-chemical diagnostics
  • Laboratory medical research
  • Quality management in laboratory diagnostics

Publications: Over 400


Prof. Dr. med. Daniel Teupser

Position: Director of the Institute for Laboratory Medicine, LMU Klinikum München

Main research areas:

  • Cardiovascular biomarkers
  • Lipid metabolism
  • Atherosclerosis
  • Biobanking
  • Mass spectrometry-based proteomics

Publications: Over 370 scientific papers
Citations: More than 14,000


Univ.-Prof. Dr. Chrysanthi Skevaki

Position: Director of the Institute for Clinical Chemistry, Universitätsmedizin
der Johannes Gutenberg-Universität Mainz

Main research areas:

  • Clinical-chemical diagnostics
  • Immunology
  • Virology

Publications: Over 120